Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors
Wataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, Taizo Uchimoto, Kazuki Nishimura, Takafumi Yanagisawa, Yu Imai, Kosuke Iwatani, Kagenori Ito, Fumihiko Urabe, Shunsuke Tsuzuki, Shoji Kimura, Naoki Terada, Shoichiro Mukai, Yu Oyama, Hirokazu Abe, Toshiyuki Kamoto, Haruhito Azuma, Jun Miki, Shin Egawa
Topics & Concepts
PembrolizumabMedicineHazard ratioInternal medicineProportional hazards modelConfidence intervalOncologyLogistic regressionCancerGastroenterologyImmunotherapyEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersATP Synthase and ATPases Research